COUP-TFII in Health and Disease

The nuclear receptors (NRs) belong to a vast family of evolutionary conserved proteins acting as ligand-activated transcription factors. Functionally, NRs are essential in embryogenesis and organogenesis and in adulthood they are involved in almost every physiological and pathological process. Our knowledge of NRs action has greatly improved in recent years, demonstrating that both their expression and activity are tightly regulated by a network of signaling pathways, miRNA and reciprocal interactions. The Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII, NR2F2) is a NR classified as an orphan due to the lack of a known natural ligand. Although its expression peaks during development, and then decreases considerably, in adult tissues, COUP-TFII is an important regulator of differentiation and it is variably implicated in tissues homeostasis. As such, alterations of its expression or its transcriptional activity have been studied and linked to a spectrum of diseases in organs and tissues of different origins. Indeed, an altered COUP-TFII expression and activity may cause infertility, abnormality in the vascular system and metabolic diseases like diabetes. Moreover, COUP-TFII is actively investigated in cancer research but its role in tumor progression is yet to be fully understood. In this review, we summarize the current understanding of COUP-TFII in healthy and pathological conditions, proposing an updated and critical view of the many functions of this NR.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Cells - 9(2019), 1 vom: 31. Dez.

Sprache:

Englisch

Beteiligte Personen:

Polvani, Simone [VerfasserIn]
Pepe, Sara [VerfasserIn]
Milani, Stefano [VerfasserIn]
Galli, Andrea [VerfasserIn]

Links:

Volltext

Themen:

Angiogenesis
COUP Transcription Factor II
COUP-TFII
Cancer
Development
EMT
Journal Article
Metabolism
NF-κB
NR2F2
Review

Anmerkungen:

Date Completed 03.09.2020

Date Revised 03.11.2023

published: Electronic

Citation Status MEDLINE

doi:

10.3390/cells9010101

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305056212